Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iridex Corporation
Mountain View, California, United Statesiridex.com ↗
- Ownership
- Public · IRIX
- Employees
- ~141
- Development stage
- Commercial
01
Overview
Iridex’s proprietary MicroPulse® technology provides tissue-sparing laser therapy for glaucoma and retinal disorders. Clinical results demonstrate safety and efficacy in reducing intraocular pressure in glaucoma patients as well as treating diabetic macular edema with minimal collateral damage. The company continues to innovate with new product launches such as the next-generation PASCAL® system. Recent clinical collaborations include a study on MicroPulse TLT with Imperial College Healthcare NHS Trust. Financially, the company reported $48.7 million revenue in FY2024. Strategic review ongoing; recently recapitalized via investment from Novel.
- Therapeutic areas
- Ophthalmology
- Modalities
- Laser-based medical devices and therapies (MicroPulse® laser technology)Sub-threshold retinal laser therapy (Endpoint Management™/EpM)Light-based treatments for glaucoma and retinal diseases
- Industry
- Therapeutic Medical Devices
02
Partnerships
Strategic investment/collaboration agreement with NovelClinical collaboration with Imperial College Healthcare NHS Trust on MicroPulse TLT study
03
Financials
- Market cap
- $11.8M
- Total revenue
- $12.6M
- Enterprise value
- $11.1M
Beyond the preview
Go deeper on Iridex Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Iridex Corporation.